Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 Visualizações
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Mostre mais
Comentários do Facebook
Nenhum comentário encontrado